COO
COOPER COMPANIES, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$55.29
+2.82%Next report
Analyst consensus
- Next report date
- Dec 3, 2026
- EPS estimate
- $1.08
- Revenue estimate
- $1.1B
Latest reported
- Last report date
- Sep 9, 2026
- EPS actual
- $1.15
- EPS estimate
- $1.12
- Revenue actual
- $1.1B
- Revenue estimate
- $1.1B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +5.7%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $65
- PT range
- $58 – $75
- Analysts
- 12
4 Buy8 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 9, 2026 | $1.12 | $1.15 | Beat 2.40% | $1.1B |
| Jun 4, 2026 | $1.10 | $1.21 | Beat 10.00% | $1.1B |
| Mar 5, 2026 | $1.03 | $1.10 | Beat 6.80% | $1.0B |
| Dec 4, 2025 | $1.11 | $1.15 | Beat 3.51% | $1.1B |
| Aug 27, 2025 | $1.07 | $1.10 | Beat 2.80% | $1.1B |
| May 29, 2025 | $0.93 | $0.96 | Beat 3.34% | $1.0B |
| Mar 6, 2025 | $0.92 | $0.92 | Beat 0.55% | $964.7M |
| Dec 5, 2024 | $1.00 | $1.04 | Beat 4.00% | $1.0B |
| Aug 28, 2024 | $0.91 | $0.96 | Beat 5.26% | $1.0B |
| May 30, 2024 | $0.83 | $0.85 | Beat 2.53% | $942.6M |
| Feb 29, 2024 | $0.78 | $0.85 | Beat 8.70% | $931.6M |
| Dec 7, 2023 | $0.87 | $0.87 | Beat 0.46% | $927.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 3, 2026